Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.
CONCLUSIONS: Our data reveal the promising role of Leonurine hydrochloride in the prevention and treatment of NASH, in vitro and in vivo. This effect may be partially mediated by the AMPK/SREBP1 pathway. These findings provide a novel therapeutic target for the clinical treatment of NASH.
PMID: 30537674 [PubMed - as supplied by publisher]
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Zhang L, Li HX, Pan WS, Khan FU, Qian C, Qi-Li FR, Xu X Tags: Biomed Pharmacother Source Type: research
More News: Alcoholism | Diets | Drugs & Pharmacology | Genetics | Liver | Metabolic Syndrome | Nutrition | Study | Urology & Nephrology